Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Cardiff Oncology Inc’s current trading price is -25.55% away from its 52-week high, while its distance from the 52-week low is 189.70%. The stock’s price range over this period has fluctuated between $1.65 and $6.42. The company, operating within the financial sector, had a trading volume of approximately 1.9 million for the day, which was noticeably lower than the average daily share volume of 2.08 million over the last 3 months.
Cardiff Oncology Inc experienced a rather steady stock market performance. The highest value in the past year was recorded at $6.42 on 03/25/24 and the lowest value was $1.65 on 02/23/24.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Cardiff Oncology Inc (CRDF) has experienced a quarterly rise of 68.31% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 317.96M and boasts a workforce of 32 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.38, with a change in price of +2.16. Similarly, Cardiff Oncology Inc recorded 1,604,869 in trading volume during the last 100 days, posting a change of +82.44%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for CRDF stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.02.
CRDF Stock Stochastic Average
Today, Cardiff Oncology Inc’s raw stochastic average for the past 50 days stands at 74.57%, indicating a decline from the raw stochastic average of the last 20 days, which was 95.03%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 74.51% and 67.38% respectively.
CRDF Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The metric has seen a significant gain of 10.14% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 100.00%. Over the past 30 days, the price of CRDF has fallen by 38.55%. And in the last five days, it has surged by 14.90%.
